Actively Recruiting
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
Led by Institute of Hematology & Blood Diseases Hospital, China · Updated on 2025-02-24
50
Participants Needed
1
Research Sites
339 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluation of immune status before and after splenectomy in immune thrombocytopenia patients.
CONDITIONS
Official Title
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 to 60 years old, male or female
- Diagnosed with immune thrombocytopenia (ITP)
- Need to have a splenectomy
- Willing to sign informed consent and follow the study procedures
You will not qualify if you...
- Have secondary thrombocytopenic purpura
- Have poor compliance
- Considered unsuitable by researchers to participate due to any other condition
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yunfei Chen
Tianjin, Tianjin Municipality, China, 300020
Actively Recruiting
Research Team
Y
Yunfei Chen, MD
CONTACT
L
Lei Zhang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here